Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Februar 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.6k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • JørgenVarnæsJ Offline
    JørgenVarnæsJ Offline
    JørgenVarnæs
    wrote on sidst redigeret af
    #143

    Troldmanden - har du styr på om en hexa-cd20 kunne være aktuel i cll? GEN fik vist rettighederne til cancer tilbage fra GSK

    1 Reply Last reply
    0
    • G Offline
      G Offline
      GeorgeBest
      wrote on sidst redigeret af
      #144

      hexa-cd20? Hvis du mener hexa-cd38 er svaret ja https://ir.genmab.com/news-releases/news-release-details/genmab-signs-agreement-janssen-next-generation-cd38-antibody/

      1 Reply Last reply
      0
      • JørgenVarnæsJ Offline
        JørgenVarnæsJ Offline
        JørgenVarnæs
        wrote on sidst redigeret af
        #145

        Det er måske epcoritamab, der er det primære program i det space? Umiddelbart mangler vi stadig PoC på hexa teknologien

        1 Reply Last reply
        0
        • G Offline
          G Offline
          gentogen
          wrote on sidst redigeret af
          #146

          hexamerization-enhanced CD20 and CD37 antibodies cooperated in C1q binding and induced superior and synergistic complement-dependent cytotoxicity

          1 Reply Last reply
          0
          • G Offline
            G Offline
            gentogen
            wrote on sidst redigeret af
            #147

            Link Preview Image
            CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering - PubMed

            CD20 monoclonal antibody therapies have significantly improved the outlook for patients with B-cell malignancies. However, many patients acquire resistance, demonstrating the need for new and improved drugs. We previously demonstrated that the natural process of antibody hexamer formation on targete …

            favicon

            PubMed (pubmed.ncbi.nlm.nih.gov)

            1 Reply Last reply
            0
            • JørgenVarnæsJ Offline
              JørgenVarnæsJ Offline
              JørgenVarnæs
              wrote on sidst redigeret af
              #148

              gad vide om det er en duo-hexa, de varmer op til der?

              1 Reply Last reply
              0
              • JørgenVarnæsJ Offline
                JørgenVarnæsJ Offline
                JørgenVarnæs
                wrote on sidst redigeret af
                #149

                det kunne tyde på, at den rene hexcd20 ikke ligger i kortene

                1 Reply Last reply
                0
                • S Offline
                  S Offline
                  Sukkeralf
                  wrote on sidst redigeret af
                  #150

                  Genmab har jo sammen med Abbvie et hexaboostet CD37 BsAb, som evt kan kombineres med CD20 hvis alt falsker sig

                  1 Reply Last reply
                  0
                  • S Offline
                    S Offline
                    Sukkeralf
                    wrote on sidst redigeret af
                    #151

                    Ofatumumab var i forvejen optimeret til at have bedre CDC end rituxan og det endte jo ikke så godt ud - og hexabody fremmer primært CDC, så nok derfor de ikke går den vej

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Sukkeralf
                      wrote on sidst redigeret af
                      #152

                      Desuden er CD20 området esktremt konkurrencepræget

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        peter12
                        wrote on sidst redigeret af
                        #153

                        Man må håbe at Hexa-cd38 ikke virker alt for godt heller, så der bliver sikkerheds issues

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          peter12
                          wrote on sidst redigeret af
                          #154

                          Webcastet var Morgan Stanley 15/9 men det er væk nu desværre

                          1 Reply Last reply
                          0
                          • Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktør
                            wrote on sidst redigeret af
                            #155

                            God morgen. 🙂

                            1 Reply Last reply
                            0
                            • Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktør
                              wrote on sidst redigeret af
                              #156

                              Asien: Solide stigninger næsten overalt i regionen: https://www.proinvestor.com/investornyt/671857/asien-solide-stigninger-naesten-overalt-i-regionen

                              1 Reply Last reply
                              0
                              • Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktør
                                wrote on sidst redigeret af
                                #157

                                Mandagens aviser med Carlsberg, Parken og Chr. Hansen: https://www.proinvestor.com/investornyt/671856/mandagens-aviser-med-carlsberg-parken-og-chr-hansen

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  Plimsoller
                                  wrote on sidst redigeret af
                                  #158

                                  God morgen 🙂

                                  1 Reply Last reply
                                  0
                                  • StockBullS Offline
                                    StockBullS Offline
                                    StockBull
                                    wrote on sidst redigeret af
                                    #159

                                    Genmab ligger stadig stabilt i trend kanalen fra Juni 2020 som indikere realistisk 12 mdr Genmab target 3000 kr https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/90798_Interessandt_trend_fra_Juni_2020.JPG

                                    1 Reply Last reply
                                    0
                                    • K Offline
                                      K Offline
                                      Klarussen
                                      wrote on sidst redigeret af
                                      #160

                                      Og om 3 år?

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #161

                                        Treatment of Antibody-Mediated Post-Transplant Autoimmune-like Hepatitis with Daratumumab https://tct.confex.com/tct/2021/meetingapp.cgi/Paper/17519

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #162

                                          Conclusions

                                          Now 10 months post-HCT, the patient is off all hepatic supportive care and steroids have gradually been weaned. He remains negative for minimal residual disease and BCR-ABL fusion transcript and 100% donor chimerism. The dramatic response documented in this patient warrants further investigation of daratumumab for plasma cell-mediated autoimmune-like hepatitis in the post-transplant setting.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger